Saroglitazar delivers positive Phase III results in rare liver disease PBC, U.S. filing planned 6 months ago ByJohnIn Pharma Industry UpdatesTop Stories
FDA approves Dupixent for chronic spontaneous urticaria in ages 12 and up 6 months ago ByJohnIn Breaking NewsFDA Approvals
FDA updates label for mavacamten after long-term studies show durable benefit in obstructive hypertrophic cardiomyopathy 6 months ago ByJohnIn BreakthroughsFDA ApprovalsResearch UpdatesTop Stories
Glycomine raises $115 million to push PMM2-CDG therapy into Phase 2b trial 6 months ago ByJohnIn InvestmentsPeopleVenture Capital
EU Unveils Public Clinical Trial Map to Boost Transparency and Patient Access 6 months ago ByJohnIn Featured AnalysisTop Stories
WHO Sparks Global Clinical Trials Momentum with Forum to Fast-Track Innovation 6 months ago ByJohnIn BreakthroughsIndustry ConferencesResearch Updates
Australia Boosts Brain Cancer Research with $5.9 Million Grant for Innovative Chair 6 months ago ByJohnIn Biopharma HighlightsPartnershipsPeople
UK Sets Stage for Smoother Clinical Trials with New Law Expected by Mid-April 6 months ago ByJohnIn BreakthroughsClinical TrialsPeople
Emerging biotechs increasingly driving drug approvals, reshaping industry dynamics 6 months ago ByJohnIn Biopharma HighlightsClinical Trials
Precision Psychiatry Breakthrough: BH-200 Antidepressant Combined with Genetic Testing Delivers Strong Response in Major Depression Trial 6 months ago ByJohnIn Research UpdatesTop Stories
FDA approves novel immunotherapy combo for colorectal cancer and clears new surgery technology 6 months ago ByJohnIn DealsFDA ApprovalsResearch Updates
MHRA unveils first-ever analysis of UK clinical trial applications, offering new roadmap for research growth 6 months ago ByJohnIn Breaking NewsClinical TrialsFeatured Analysis
New clinical trial regulations take effect in the UK as pandemic case rates remain steady 6 months ago ByJohnIn Industry ConferencesPharma Industry UpdatesTop Stories
UK Unveils Major Push to Accelerate Clinical Trials and Health Data Access 6 months ago ByJohnIn Biopharma HighlightsFeatured AnalysisIndustry ConferencesResearch Updates
PTC Therapeutics reports promising Phase 2 results in Huntington’s disease program 6 months ago ByJohnIn Clinical TrialsFeatured AnalysisResearch UpdatesTop Stories
